WO2002055681A3 - Regulation de la tau-tubuline kinase humaine - Google Patents

Regulation de la tau-tubuline kinase humaine Download PDF

Info

Publication number
WO2002055681A3
WO2002055681A3 PCT/EP2002/000157 EP0200157W WO02055681A3 WO 2002055681 A3 WO2002055681 A3 WO 2002055681A3 EP 0200157 W EP0200157 W EP 0200157W WO 02055681 A3 WO02055681 A3 WO 02055681A3
Authority
WO
WIPO (PCT)
Prior art keywords
human tau
tubulin kinase
regulation
reagents
tubulin
Prior art date
Application number
PCT/EP2002/000157
Other languages
English (en)
Other versions
WO2002055681A2 (fr
Inventor
Jiing-Ren Liou
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Priority to AU2002231741A priority Critical patent/AU2002231741A1/en
Publication of WO2002055681A2 publication Critical patent/WO2002055681A2/fr
Publication of WO2002055681A3 publication Critical patent/WO2002055681A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des réactifs qui régulent la tau-tubuline kinase humaine, ainsi que des réactifs qui se lient avec les produits géniques de la tau-tubuline kinase humaine. Ces réactifs peuvent jouer un rôle dans la prévention, l'amélioration ou la correction de dysfonctions ou de pathologies, notamment mais non exclusivement la BPCO, les troubles du système nerveux périphérique et central, et les maladies cardio-vasculaires.
PCT/EP2002/000157 2001-01-11 2002-01-10 Regulation de la tau-tubuline kinase humaine WO2002055681A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002231741A AU2002231741A1 (en) 2001-01-11 2002-01-10 Regulation of human tau-tubulin kinase

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US26064901P 2001-01-11 2001-01-11
US60/260,649 2001-01-11
US30761501P 2001-07-26 2001-07-26
US60/307,615 2001-07-26
US31383001P 2001-08-22 2001-08-22
US60/313,830 2001-08-22

Publications (2)

Publication Number Publication Date
WO2002055681A2 WO2002055681A2 (fr) 2002-07-18
WO2002055681A3 true WO2002055681A3 (fr) 2003-03-27

Family

ID=27401332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/000157 WO2002055681A2 (fr) 2001-01-11 2002-01-10 Regulation de la tau-tubuline kinase humaine

Country Status (2)

Country Link
AU (1) AU2002231741A1 (fr)
WO (1) WO2002055681A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003023034A2 (fr) * 2001-09-12 2003-03-20 Bayer Healthcare Ag Regulation de tau-tubuline kinase humaine
JOP20200228A1 (ar) 2015-12-21 2017-06-16 Novartis Ag تركيبات وطرق لخفض تعبير البروتين tau

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073469A2 (fr) * 1999-05-28 2000-12-07 Sugen, Inc. Proteines kinases
WO2001073050A2 (fr) * 2000-03-24 2001-10-04 Millennium Pharmaceuticals, Inc. 3714, 16742, 23546, et 13887 nouvelles molecules de proteine kinase et leurs utilisations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073469A2 (fr) * 1999-05-28 2000-12-07 Sugen, Inc. Proteines kinases
WO2001073050A2 (fr) * 2000-03-24 2001-10-04 Millennium Pharmaceuticals, Inc. 3714, 16742, 23546, et 13887 nouvelles molecules de proteine kinase et leurs utilisations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MORISHIMA-KAWASHIMA MAHO ET AL: "Proline-directed and non-proline-directed phosphorylation of PHF-tau.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 2, 1995, pages 823 - 829, XP002224023, ISSN: 0021-9258 *
REYNOLDS C HUGH ET AL: "Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3beta.", JOURNAL OF NEUROCHEMISTRY, vol. 74, no. 4, April 2000 (2000-04-01), pages 1587 - 1595, XP002224024, ISSN: 0022-3042 *
TAKAHASHI MIHO ET AL: "A novel tau-tubulin kinase from bovine brain.", FEBS LETTERS, vol. 372, no. 1, 1995, pages 59 - 64, XP002224022, ISSN: 0014-5793 *
TOMIZAWA KAYOKO ET AL: "Tau-tubulin kinase phosphorylates tau at Ser-208 and Ser-210, sites found in paired helical filament-tau.", FEBS LETTERS, vol. 492, no. 3, March 2001 (2001-03-01), pages 221 - 227, XP002224031, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
WO2002055681A2 (fr) 2002-07-18
AU2002231741A1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
WO2002004610A3 (fr) Regulation d'une enzyme humaine du type dipeptidyl-peptidase iv
WO2002055681A3 (fr) Regulation de la tau-tubuline kinase humaine
WO2001077149A3 (fr) Regulation d'une proteine gpcr type cyslt2 humaine
WO2002006453A3 (fr) Regulation de protease a serine humaine de type desc1
WO2002053749A3 (fr) Regulation de la proteine kinase serine/threonine humaine
WO2002057461A3 (fr) Regulation de la metalloprotease a zinc de type adam-ts humaine
WO2002061057A3 (fr) Regulation de la serine/threonine proteine kinase humaine de type wee1
WO2003025174A3 (fr) Regulation de la proteine humaine de type mrp1
WO2003033708A3 (fr) Regulation de la proteine kinase humaine a serine/threonine
WO2003052088A3 (fr) Regulation de la sialyltransferase humaine
WO2002036613A3 (fr) Regulation de la proteine humaine de type 'patched'
WO2002048358A3 (fr) Regulation du recepteur humain de type chimiokine
WO2003018815A3 (fr) Regulation de la grk humaine
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2003033709A3 (fr) Regulation de la proteine kinase serine/threonine humaine
WO2002046403A3 (fr) Regulation de la proteine humaine du type 'patched'
WO2002033056A3 (fr) Regulation de serine-threonine kinase humaine
WO2003023034A3 (fr) Regulation de tau-tubuline kinase humaine
WO2003035859A3 (fr) Regulation de la serine/threonine kinase humaine
WO2002036731A3 (fr) Lipase acide lysosomiale de l'homme
WO2003000903A3 (fr) Regulation de serine/threonine proteine kinase humaine de type nek
WO2002033095A3 (fr) Regulation de serine-threonine proteine kinase humaine
WO2002070678A3 (fr) Regulation de la serine/threonine proteine kinase humaine
WO2002062975A3 (fr) Regulation de la proteine humaine du type elongase hselo1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP